Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 13 04:00PM ET
1.85
Dollar change
-0.02
Percentage change
-1.07
%
Index- P/E- EPS (ttm)-5.81 Insider Own11.10% Shs Outstand93.11M Perf Week-11.90%
Market Cap32.40M Forward P/E- EPS next Y-0.78 Insider Trans0.00% Shs Float15.57M Perf Month-45.27%
Income-27.95M PEG- EPS next Q-0.37 Inst Own1.75% Short Float5.90% Perf Quarter56.78%
Sales0.00M P/S- EPS this Y78.64% Inst Trans-39.31% Short Ratio0.64 Perf Half Y-9.31%
Book/sh-0.11 P/B- EPS next Y79.03% ROA-208.17% Short Interest0.92M Perf Year-91.92%
Cash/sh0.11 P/C16.20 EPS next 5Y- ROE-238.50% 52W Range0.73 - 24.00 Perf YTD-87.75%
Dividend Est.- P/FCF- EPS past 5Y- ROI- 52W High-92.29% Beta1.05
Dividend TTM- Quick Ratio0.19 Sales past 5Y-50.00% Gross Margin- 52W Low153.42% ATR (14)0.26
Dividend Ex-Date- Current Ratio0.19 EPS Y/Y TTM45.23% Oper. Margin- RSI (14)48.19 Volatility10.86% 13.22%
Employees41 Debt/Eq- Sales Y/Y TTM- Profit Margin- Recom1.50 Target Price6.25
Option/ShortNo / Yes LT Debt/Eq- EPS Q/Q95.43% Payout- Rel Volume1.12 Prev Close1.87
Sales Surprise- EPS Surprise24.02% Sales Q/Q- EarningsNov 12 AMC Avg Volume1.44M Price1.85
SMA20-10.89% SMA5014.24% SMA200-21.27% Trades Volume1,619,155 Change-1.07%
Date Action Analyst Rating Change Price Target Change
Nov-22-23Initiated H.C. Wainwright Buy $11
Oct-09-23Initiated Robert W. Baird Outperform $9
Nov-18-24 08:00AM
Nov-15-24 04:05PM
Nov-14-24 08:30AM
Nov-13-24 04:33PM
Nov-12-24 05:29PM
09:00AM Loading…
Oct-25-24 09:00AM
Oct-24-24 08:35AM
08:30AM
Oct-23-24 08:31AM
Oct-19-24 05:48PM
Oct-18-24 11:00PM
08:45AM
Sep-30-24 08:00AM
Aug-13-24 05:37PM
Aug-02-24 09:00AM
09:00AM Loading…
Jul-29-24 09:00AM
Jul-18-24 08:00AM
Jul-16-24 08:00AM
Jul-05-24 04:15PM
Jun-27-24 07:00AM
Jun-11-24 04:05PM
Jun-10-24 07:00AM
Jun-03-24 07:00AM
May-31-24 08:51AM
May-24-24 09:00AM
May-17-24 09:00AM
May-14-24 04:05PM
May-07-24 09:15AM
May-01-24 07:00AM
Apr-23-24 07:00AM
04:05PM Loading…
Apr-19-24 04:05PM
Apr-16-24 08:31AM
Apr-09-24 07:00AM
Mar-15-24 04:05PM
Mar-11-24 07:00AM
Feb-12-24 07:00AM
Jan-08-24 07:00AM
Dec-13-23 07:00AM
Dec-12-23 07:00AM
Nov-20-23 07:00AM
Nov-14-23 04:05PM
Nov-03-23 07:00AM
Nov-01-23 07:00AM
Oct-30-23 07:00AM
Oct-10-23 07:00AM
Sep-13-23 05:50AM
Sep-11-23 04:05PM
Aug-24-23 12:06PM
Aug-22-23 11:41AM
Aug-16-23 06:00AM
Aug-07-23 05:00AM
Jun-23-23 05:00AM
Calidi Biotherapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which engages in stem cell-based platforms to revolutionize oncolytic virotherapies. The company was founded in 2014 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Schoeneck James ADirectorJun 03 '24Option Exercise0.20548,000109,600963,887Jun 05 04:15 PM